A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants
Clinical trial NCT05909852 · COMPLETED
Trial details
- NCT number
- NCT05909852
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2021-11-24
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.